202 related articles for article (PubMed ID: 23363053)
1. Peptide ligands for pro-survival protein Bfl-1 from computationally guided library screening.
Dutta S; Chen TS; Keating AE
ACS Chem Biol; 2013 Apr; 8(4):778-88. PubMed ID: 23363053
[TBL] [Abstract][Full Text] [Related]
2. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
Modi V; Lama D; Sankararamakrishnan R
J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
[TBL] [Abstract][Full Text] [Related]
3. Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL.
Dutta S; Gullá S; Chen TS; Fire E; Grant RA; Keating AE
J Mol Biol; 2010 May; 398(5):747-62. PubMed ID: 20363230
[TBL] [Abstract][Full Text] [Related]
4. Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL.
Dutta S; Ryan J; Chen TS; Kougentakis C; Letai A; Keating AE
J Mol Biol; 2015 Mar; 427(6 Pt B):1241-1253. PubMed ID: 25451027
[TBL] [Abstract][Full Text] [Related]
5. Crystal Structures of Anti-apoptotic BFL-1 and Its Complex with a Covalent Stapled Peptide Inhibitor.
Harvey EP; Seo HS; Guerra RM; Bird GH; Dhe-Paganon S; Walensky LD
Structure; 2018 Jan; 26(1):153-160.e4. PubMed ID: 29276033
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide prediction and validation of peptides that bind human prosurvival Bcl-2 proteins.
DeBartolo J; Taipale M; Keating AE
PLoS Comput Biol; 2014 Jun; 10(6):e1003693. PubMed ID: 24967846
[TBL] [Abstract][Full Text] [Related]
7. Locating Herpesvirus Bcl-2 Homologs in the Specificity Landscape of Anti-Apoptotic Bcl-2 Proteins.
Foight GW; Keating AE
J Mol Biol; 2015 Jul; 427(15):2468-2490. PubMed ID: 26009469
[TBL] [Abstract][Full Text] [Related]
8. Novel Bcl-2 homology-3 domain-like sequences identified from screening randomized peptide libraries for inhibitors of the pro-survival Bcl-2 proteins.
Lee EF; Fedorova A; Zobel K; Boyle MJ; Yang H; Perugini MA; Colman PM; Huang DC; Deshayes K; Fairlie WD
J Biol Chem; 2009 Nov; 284(45):31315-26. PubMed ID: 19748896
[TBL] [Abstract][Full Text] [Related]
9. hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents.
Barile E; Marconi GD; De SK; Baggio C; Gambini L; Salem AF; Kashyap MK; Castro JE; Kipps TJ; Pellecchia M
ACS Chem Biol; 2017 Feb; 12(2):444-455. PubMed ID: 28026162
[TBL] [Abstract][Full Text] [Related]
10. A comparison of two strategies for affinity maturation of a BH3 peptide toward pro-survival Bcl-2 proteins.
Zhang S; Long A; Link AJ
ACS Synth Biol; 2012 Mar; 1(3):89-98. PubMed ID: 23651073
[TBL] [Abstract][Full Text] [Related]
11. Selective Covalent Targeting of Anti-Apoptotic BFL-1 by Cysteine-Reactive Stapled Peptide Inhibitors.
Huhn AJ; Guerra RM; Harvey EP; Bird GH; Walensky LD
Cell Chem Biol; 2016 Sep; 23(9):1123-1134. PubMed ID: 27617850
[TBL] [Abstract][Full Text] [Related]
12. Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737.
Mathieu AL; Sperandio O; Pottiez V; Balzarin S; Herlédan A; Elkaïm JO; Fogeron ML; Piveteau C; Dassonneville S; Deprez B; Villoutreix BO; Bonnefoy N; Leroux F
J Biomol Screen; 2014 Aug; 19(7):1035-46. PubMed ID: 24809353
[TBL] [Abstract][Full Text] [Related]
13. Tertiary Structural Motif Sequence Statistics Enable Facile Prediction and Design of Peptides that Bind Anti-apoptotic Bfl-1 and Mcl-1.
Frappier V; Jenson JM; Zhou J; Grigoryan G; Keating AE
Structure; 2019 Apr; 27(4):606-617.e5. PubMed ID: 30773399
[TBL] [Abstract][Full Text] [Related]
14. Designed BH3 peptides with high affinity and specificity for targeting Mcl-1 in cells.
Foight GW; Ryan JA; Gullá SV; Letai A; Keating AE
ACS Chem Biol; 2014 Sep; 9(9):1962-8. PubMed ID: 25052212
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B.
Rooswinkel RW; van de Kooij B; Verheij M; Borst J
Cell Death Dis; 2012 Aug; 3(8):e366. PubMed ID: 22875003
[TBL] [Abstract][Full Text] [Related]
16. Completing the family portrait of the anti-apoptotic Bcl-2 proteins: crystal structure of human Bfl-1 in complex with Bim.
Herman MD; Nyman T; Welin M; Lehtiö L; Flodin S; Trésaugues L; Kotenyova T; Flores A; Nordlund P
FEBS Lett; 2008 Oct; 582(25-26):3590-4. PubMed ID: 18812174
[TBL] [Abstract][Full Text] [Related]
17. Epistatic mutations in PUMA BH3 drive an alternate binding mode to potently and selectively inhibit anti-apoptotic Bfl-1.
Jenson JM; Ryan JA; Grant RA; Letai A; Keating AE
Elife; 2017 Jun; 6():. PubMed ID: 28594323
[TBL] [Abstract][Full Text] [Related]
18. Characterization of peptide aptamers targeting Bfl-1 anti-apoptotic protein.
Brien G; Debaud AL; Bickle M; Trescol-Biemont MC; Moncorge O; Colas P; Bonnefoy-Berard N
Biochemistry; 2011 Jun; 50(23):5120-9. PubMed ID: 21563784
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit is collaboration with pro-apoptotic Bak or Bax.
Werner AB; de Vries E; Tait SW; Bontjer I; Borst J
J Biol Chem; 2002 Jun; 277(25):22781-8. PubMed ID: 11929871
[TBL] [Abstract][Full Text] [Related]
20. Selective Covalent Targeting of Anti-apoptotic BFL-1 by a Sulfonium-Tethered Peptide.
Liu N; Wang D; Lian C; Zhao R; Tu L; Zhang Y; Liu J; Zhu H; Yu M; Wan C; Li D; Li S; Yin F; Li Z
Chembiochem; 2021 Jan; 22(2):340-344. PubMed ID: 32790056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
